Yamada J, Horie S, Watanabe T, Suga T
Biochem Biophys Res Commun. 1984 Nov 30;125(1):123-8. doi: 10.1016/s0006-291x(84)80343-5.
A drug, (E)-3-[4-(1-imidazolylmethyl)phenyl]-2-propenoic acid, was metabolized to 4-(1-imidazolylmethyl)benzoic acid in isolated hepatocytes of rats, which was enhanced markedly by the pretreatment of rats with clofibrate. With liver homogenates, the formation of the CoA-ester of this drug and its subsequent chain-shortening were demonstrated. In the series of these reactions, acyl-CoA synthetase, CoA, ATP and NAD were required, whereas cyanide did not inhibit the reaction. These results indicate that peroxisomes are capable of shortening the acyl side-chains of drugs by the beta-oxidation, giving an additional suggestion on the functions of peroxisomes.
一种药物,(E)-3-[4-(1-咪唑基甲基)苯基]-2-丙烯酸,在大鼠离体肝细胞中代谢为4-(1-咪唑基甲基)苯甲酸,用氯贝丁酯预处理大鼠可显著增强这种代谢。用肝匀浆证明了该药物的辅酶A酯的形成及其随后的链缩短。在这些反应系列中,需要酰基辅酶A合成酶、辅酶A、三磷酸腺苷和烟酰胺腺嘌呤二核苷酸,而氰化物不抑制该反应。这些结果表明过氧化物酶体能够通过β-氧化缩短药物的酰基侧链,这为过氧化物酶体的功能提供了额外的线索。